ZERO—The End of Prostate Cancer

Leading National Prostate Cancer Nonprofit Announces Return of Annual Run/Walk Series

Retrieved on: 
Tuesday, April 25, 2023
Survivor, Prostate cancer, Friends, Revlon Run Walk, ZERO—The End of Prostate Cancer, ZERO, AstraZeneca, Athlete, Bayer, Lilly, Patient, Physician, Roivant Sciences, City, Disease, Caregiver, Dairy, Pharmaceutical industry, Event

WASHINGTON, April 25, 2023 /PRNewswire/ -- ZERO Prostate Cancer is proud to announce the return of its annual celebration of prostate cancer patients, survivors, caregivers, and families with its national Run/Walk series. This year, ZERO joins forces with fifty U.S. cities in the upcoming ZERO Prostate Cancer Run/Walk series.

Key Points: 
  • WASHINGTON, April 25, 2023 /PRNewswire/ -- ZERO Prostate Cancer is proud to announce the return of its annual celebration of prostate cancer patients, survivors, caregivers, and families with its national Run/Walk series .
  • This year, ZERO joins forces with fifty U.S. cities in the upcoming ZERO Prostate Cancer Run/Walk series.
  • "As the largest men's health event series in the world, the ZERO Prostate Cancer Run|Walk series shares hope, inspires action, and builds community among patients and the people who love them," said Jamie Bearse, ZERO Prostate Cancer's CEO.
  • "We are thrilled to have fifty communities nationwide that have committed to raising significant funds and awareness, building local prostate cancer communities, and ending prostate cancer," said Tracy Cesaretti, ZERO Prostate Cancer's Vice President of Events.

Prevent Cancer Foundation champions introduction of Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act in the House

Retrieved on: 
Monday, April 3, 2023
CMS, Prevent Cancer Foundation, Centers for Medicare & Medicaid Services, Public, Cancer, Quality of life, Center for Medicare and Medicaid Innovation, Breast, Lung, Medicare, Organization, Congress, History of the Food and Drug Administration, ZERO—The End of Prostate Cancer, Representative, Patient, Mortality, Louisiana House of Representatives, FDA, Health, House, Food, Caregiver, Legislation, Pharmaceutical industry, Mobile phone, Policy

The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act will allow older Americans with Medicare the possibility of access to multi-cancer early detection (MCED) tests once they are approved by the Food and Drug Administration (FDA) and shown to have clinical benefit.

Key Points: 
  • The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act will allow older Americans with Medicare the possibility of access to multi-cancer early detection (MCED) tests once they are approved by the Food and Drug Administration (FDA) and shown to have clinical benefit.
  • For two years, the Prevent Cancer Foundation has led more than 400 organizations from all 50 states in support of the Medicare Multi-Cancer Early Detection Screening Coverage Act.
  • The Prevent Cancer Foundation has always been a champion for cancer prevention and early detection efforts.
  • If you are with an advocacy, medical, community or public health focused organization interested in joining the Prevent Cancer Foundation in support of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, contact Caitlin Kubler, Director of Policy and Advocacy, at [email protected].

Mediaplanet and Jenifer Lewis Team Up to Celebrate Black History

Retrieved on: 
Tuesday, February 28, 2023
Mania, Social media, Prostate cancer, American Heart Association, Depression, Interview, ZERO—The End of Prostate Cancer, Black History Month, Los, ZERO, Grandiosity, Science, Color of Change, Bipolar disorder, Health, Los Angeles Times, Film industry, Black

NEW YORK, Feb. 28, 2023 /PRNewswire-PRWeb/ -- Helping to conclude Black History Month, Mediaplanet announces the launch of this February's edition of "Celebrating Black History." This campaign will shed light on the institutional and social barriers that the Black community faces and showcase the resources that are creating more opportunities. In collaboration with leaders in health, science, and entertainment, this campaign will highlight impactful stories, achievements, and innovations in order to empower the Black community.

Key Points: 
  • Mediaplanet's Celebrating Black History campaign, found within LA Times and online, highlights black innovation.
  • NEW YORK, Feb. 28, 2023 /PRNewswire-PRWeb/ -- Helping to conclude Black History Month, Mediaplanet announces the launch of this February's edition of "Celebrating Black History."
  • The print component of "Celebrating Black History" is distributed within today's edition of LA Times with a circulation of approximately 164,000 copies and an estimated readership of 540,000.
  • To explore the digital version of the campaign, visit: https://bit.ly/3YkjLnS
    Prolific actress and activist Jenifer Lewis graces the cover of the print campaign.

AutoNation Wraps Up Year of Giving With Holiday Season Donations to Cancer Organizations

Retrieved on: 
Friday, December 30, 2022
Driscoll Children's Hospital, Hospital, Breast cancer, AutoNation, Patient, Strathcona County, Customer, Prostate cancer, NYSE, Imagine, University, Breast, Transport, Wipe Out Kids Cancer, Blog, Christmas, Buick, Metastasis, Breast Cancer Research Foundation, American Cancer Society, News, J.D. Power, Multimedia, Reputation, BMW, BCRF, ZERO—The End of Prostate Cancer, Moses Austin, Associate, Research, Cancer, Pharmaceutical industry, Toy, Car dealership

FORT LAUDERDALE, Fla., Dec. 30, 2022 /PRNewswire/ -- With its year-round Drive Pink (DRVPNK) mission,  AutoNation, Inc. (NYSE: AN) has proudly surpassed $35 million raised to help drive out cancer. Associates from coast to coast wrapped up 2022 with a flurry of initiatives to benefit children and adults whose lives have been impacted by cancer.

Key Points: 
  • Associates from coast to coast wrapped up 2022 with a flurry of initiatives to benefit children and adults whose lives have been impacted by cancer.
  • In 2022, AutoNation Customers generously donated nearly $800,000 through AutoNation's Credit Card Donation Program, with 100 percent of proceeds directly benefiting this year's national DRVPNK charity partners: American Cancer Society, Zero – The End of Prostate Cancer, National Pediatric Cancer Foundation and the Breast Cancer Research Foundation (BCRF).
  • Since 2013, AutoNation has contributed over $35 million to its extensive network of charitable community partners in support of cancer research across the spectrum, from pediatric cancer to treatments for prostate cancer and more.
  • Through its bold leadership and brand affinity, the AutoNation Brand is synonymous with "DRVPNK" and "What Drives You, Drives Us."

Veteran's Health Bill Included in End-of-Year Spending Package

Retrieved on: 
Friday, December 23, 2022
Prostate Cancer Foundation, Organization, Health policy, Patient, American Urological Association, Education, Prostate cancer, ZERO, Health, AUA, American Cancer Society, Urology, Disease, Senate, Veteran, House, Baltimore, Prostate, Electoral History of the Conservative Party of New York State (U.S. House Results), Veterans Health Administration, Congress, Legislation, Research, VHA, Cancer, ZERO—The End of Prostate Cancer, Medical imaging, MD

BALTIMORE, Dec. 23, 2022 /PRNewswire/ -- The American Urological Association (AUA) today celebrates the inclusion of the Veteran's Prostate Cancer Treatment and Research Act in Congress' end of year spending package.

Key Points: 
  • BALTIMORE, Dec. 23, 2022 /PRNewswire/ -- The American Urological Association (AUA) today celebrates the inclusion of the Veteran's Prostate Cancer Treatment and Research Act in Congress' end of year spending package.
  • This important bill supports the development and implementation of a Veterans Health Administration (VHA) healthcare program focused on coordinated and comprehensive care for veterans with prostate cancer.
  • The bill also directs the VHA to develop a national clinical pathway for prostate cancer and to design a Prostate Cancer Registry and Research Program.
  • In addition, the National Institutes of Health reports that prostate cancer is the most common cancer diagnosed in the VHA.

miR Scientific launches "Can do Blue" on September 1, 2022, as Prostate Cancer Awareness Month

Retrieved on: 
Thursday, August 18, 2022
Sentinel, Movement, American Urological Association, Prostate cancer, Risk, CEO, Trial of the century, Annual general meeting, American Cancer Society, Cancer, LLC, PCAM, Senate, Government, Mir, Science, Man, Company, Patient, SAN, Administration, RNA, Awareness, Cure, ZERO, Disease management, University, ZERO—The End of Prostate Cancer, National Prostate Health Month, Liquid biopsy, Disease, Organization, Seaweed, Medical imaging

NEW YORK and SAN JUAN, Puerto Rico, Aug. 18, 2022 /PRNewswire/ -- miR Scientific, LLC announced the launch of national event #CanDoBlue to create awareness of the need for widespread prostate cancer testing during the 2022 Prostate Cancer Awareness Month (also known as "PCAM").

Key Points: 
  • NEW YORK and SAN JUAN, Puerto Rico, Aug. 18, 2022 /PRNewswire/ -- miR Scientific, LLC announced the launch of national event #CanDoBlue to create awareness of the need for widespread prostate cancer testing during the 2022 Prostate Cancer Awareness Month (also known as "PCAM").
  • Across North America, September is recognized as Prostate Cancer Awareness Month by healthcare experts, advocates and organizations concerned with men's prostate health.
  • Last month the company announced that miR Sentinel Prostate Cancer Test is commercially available in the United States, Puerto Rico and select international markets.
  • The miR Sentinel Test assesses the risk of aggressive prostate cancer and is intended to aid in the detection and clinical management of men >45 years of age at risk for prostate cancer.

ZERO – The End of Prostate Cancer and Bayer Band Together with Twisted Sister’s Jay Jay French to Raise Awareness about Prostate Cancer Screening and Treatment

Retrieved on: 
Thursday, June 17, 2021
MEN, Research, General Health, Pharmaceutical, Oncology, Consumer, Other Education, Education, Clinical trials, Science, Biotechnology, Health, Other Science, Prostate cancer, Anatomy, Medicine, Clinical medicine, Prostate, Cancer, Screening, ZERO—The End of Prostate Cancer, National Prostate Health Month, the National Prostate Cancer Education Campaign, Prostate Cancer, Oncology at Bayer, Bayer, ZERO – The End of Prostate Cancer, THE NATIONAL PROSTATE CANCER EDUCATION CAMPAIGN, PROSTATE CANCER, ONCOLOGY AT BAYER, BAYER, ZERO – THE END OF PROSTATE CANCER

Understanding family history and other risk factors is an important step in knowing when to begin screening for prostate cancer.

Key Points: 
  • Understanding family history and other risk factors is an important step in knowing when to begin screening for prostate cancer.
  • Were Not Gonna Take It is a national education campaign to raise awareness about the importance of screening and early detection of prostate cancer.
  • With support from Bayer, ZERO is proud to partner with Jay Jay French guitarist, manager, record producer and founding member of the heavy metal band Twisted Sister.
  • ZERO The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer.

Kristen Bell Selects The Winners Of The Prostate Cancer Foundation's Fourth Annual TRUE Love Contest

Retrieved on: 
Thursday, March 11, 2021
Prostate cancer, Anatomy, Medical specialties, Branches of biology, Prostate Cancer Foundation, Cancer research, Prostate, Prostate Cancer Foundation of Australia, ZERO—The End of Prostate Cancer

LOS ANGELES, March 11, 2021 /PRNewswire/ --The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today the winners of the fourth annual TRUE Love Contest that honors caregivers and supporters of prostate cancer patients.

Key Points: 
  • LOS ANGELES, March 11, 2021 /PRNewswire/ --The Prostate Cancer Foundation (PCF) and actress Kristen Bell announced today the winners of the fourth annual TRUE Love Contest that honors caregivers and supporters of prostate cancer patients.
  • Caregivers and family are essential to a prostate cancer patient's mental health and recovery, but sometimes the role can go unrecognized," said Bell.
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research.
  • The Prostate Cancer Foundation research now impacts more than 70 forms of human cancer by focusing on immunotherapy, the microbiome, and food as medicine.

The Prostate Cancer Foundation, The Atlanta Hawks, And Other NBA Teams Join Forces For The Third Annual PCF Black History Month Assist Challenge

Retrieved on: 
Wednesday, January 27, 2021
Prostate cancer, Anatomy, Medical specialties, Branches of biology, Prostate Cancer Foundation, Prostate, ZERO—The End of Prostate Cancer, Prostate Cancer Foundation of Australia

LOS ANGELES, Jan. 27, 2021 /PRNewswire/ --The Prostate Cancer Foundation (PCF) has once again drafted teams from the NBA to help fight prostate cancer with the Third Annual PCF Black History Month Assist Challenge in February.

Key Points: 
  • LOS ANGELES, Jan. 27, 2021 /PRNewswire/ --The Prostate Cancer Foundation (PCF) has once again drafted teams from the NBA to help fight prostate cancer with the Third Annual PCF Black History Month Assist Challenge in February.
  • Black men are disproportionately impacted: One in seven will develop the disease and are almost 80 percent more likely to develop prostate cancer than White men.
  • For more information about the Black History Month Assist Challenge and prostate cancer, visit www.pcf.org/assist .
  • The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research.

Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise Awareness And Education To Empower Men With Prostate Cancer

Retrieved on: 
Tuesday, September 8, 2020
Prostate cancer, Anatomy, Branches of biology, Cancer, Prostate, Exosome complex, Prostate Cancer Foundation, ZERO—The End of Prostate Cancer

Recently the 21-year Major League veteran divulged that earlier this year he was diagnosedwith and successfully treated for prostate cancer.

Key Points: 
  • Recently the 21-year Major League veteran divulged that earlier this year he was diagnosedwith and successfully treated for prostate cancer.
  • Today Ripken, 60, is leading a national effort with Exosome Diagnostics to build education and awareness of the ExoDx Prostate test, encouragemen to proactively take action and be awareoftheir prostate health.
  • The ExoDx Prostate (EPI) test played an important role in the management of Cal's prostate cancer.
  • Currently, nearly 3.6 million American men are living with the disease only slightly less than the population of Los Angeles.